Host Jeff Voigt discusses the promise and progress of cancer vaccines, T cell therapy success and limitations, and how oncologists can use these potential tools in the treatment and prevention of cancer on The Business of Health Care.
Panelists: Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick MD Abramson Cancer Center’s Professor in Penn’s Perelman School of Medicine.
Gerald P. Linette, MD, PhD, Professor of Medicine in the division of Hematology-Oncology and Medical Director of the Sean Parker Institute of Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.
E. John Wherry, PhD, Richard and Barbara Schiffrin President’s Distinguished Professor of Microbiology and director of the Institute for Immunology at Penn.
